
BrainScape Medical
Advanced subscalp EEG system for continuous, unobtrusive brain monitoring and data collection.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | CHF100k | Debt | |
Total Funding | 000k |
Related Content
BrainScape Medical SA focuses on transforming the management and treatment of neurological and psychiatric disorders through its innovative Epios technology. The company operates in the healthcare sector, specifically targeting the need for long-term, real-world brain data collection. BrainScape's core product, Epios, is a minimally invasive, 32-channel subscalp EEG system designed for continuous monitoring outside clinical settings. This device is discreet, easy to manage, and requires no maintenance, allowing it to seamlessly integrate into patients' daily lives without disruption. The business model revolves around commercializing this technology, developed in collaboration with the Wyss Center for Bio and Neuroengineering, to provide reliable EEG signals for neurofeedback protocols and brain-computer interfaces. By advancing intensive monitoring and personalized care, BrainScape aims to drive new discoveries in brain science and improve patient outcomes. Keywords: neurological disorders, psychiatric disorders, brain monitoring, EEG system, subscalp technology, neurofeedback, brain-computer interface, data analytics, personalized care, healthcare.